# Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL

> **NCT05379569** · PHASE4 · UNKNOWN · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 142 (estimated)

## Conditions studied

- Acute B Lymphoblastic Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation

## Interventions

- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT05379569
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-15
- **Primary completion:** 2023-11-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05379569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05379569, "Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05379569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*